A prospective cohort study is conducted to evaluate the risk of acute kidney injury (AKI) associated with a newly approved intravenous antifungal medication in hospitalized patients. The initial unadjusted analysis yields a relative risk (RR) of 3.2. The investigators suspect that concurrent use of a known nephrotoxic immunosuppressant medication might be influencing these results. To investigate this, they re-analyze the data by stratifying the patients based on concurrent immunosuppressant use. In the stratum of patients taking the immunosuppressant, the RR for AKI with the new antifungal is 5.8. In the stratum of patients not taking the immunosuppressant, the RR is 1.1. Which of the following epidemiologic principles best describes the role of concurrent immunosuppressant use in this study?
- Effect modificationCevap
- BConfounding
- CSelection bias
- DInformation bias
- ELead-time bias